publication date: Dec. 19, 2010
In this issue:
Richard Klausner resigned from the Gates Foundation, saying move was unrelated to Congressional investigation of NCI contract to Harvard University during Klausner’s tenure as NCI director.
FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.
Three cancer centers joined the Multiple Myeloma Research Consortium.
Download (PDF 461KB)
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.